The medication is meant to boost ladies’ libido, and it is inserted with a pen about 45 moments in advance.
The Food And Drug Administration on Friday authorized a drug that is second to increase a lady’s sexual interest.
Approval regarding the injectable drug, bremelanotide, offered as Vyleesi by Amag Pharmaceuticals Inc., follows the unsuccessful 2015 launch regarding the medication Addyi, a controversial “female Viagra” capsule meant to spur sexual interest.
“There are ladies who, for no understood reason, have actually paid down libido that causes noticeable stress, and who is able to take advantage of effective and safe pharmacologic therapy,” Hylton Joffe associated with the Food And Drug Administration’s Center for Drug Evaluation and analysis, said in a statement. “Today’s approval provides females with another therapy choice.”